Kopran

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE082A01010
  • NSEID: KOPRAN
  • BSEID: 524280
INR
118.90
5.2 (4.57%)
BSENSE

Mar 20

BSE+NSE Vol: 2.36 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Haleos Labs Limi
Jenburkt Pharma
Albert David
Sigachi Indust.
Kopran
Themis Medicare
Shree Ganesh Rem
Kilitch Drugs
Bharat Parenter.
Anlon Healthcare
Influx Health.

Why is Kopran Ltd ?

1
Poor long term growth as Operating profit has grown by an annual rate -15.89% of over the last 5 years
2
The company has declared Negative results for the last 6 consecutive quarters
  • PBT LESS OI(Q) At Rs 10.67 cr has Fallen at -22.06%
  • ROCE(HY) Lowest at 5.38%
  • INTEREST(Q) At Rs 2.67 cr has Grown at 27.75%
3
Despite the size of the company, domestic mutual funds hold only 0.01% of the company
  • Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
4
Underperformed the market in the last 1 year
  • Even though the market (BSE500) has generated returns of 0.76% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -34.63% returns
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Kopran for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Kopran
-34.63%
-0.83
41.74%
Sensex
-2.38%
-0.19
12.70%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
7.13%
EBIT Growth (5y)
-15.89%
EBIT to Interest (avg)
7.80
Debt to EBITDA (avg)
1.59
Net Debt to Equity (avg)
0.24
Sales to Capital Employed (avg)
1.09
Tax Ratio
27.17%
Dividend Payout Ratio
37.57%
Pledged Shares
0
Institutional Holding
0.36%
ROCE (avg)
12.29%
ROE (avg)
10.74%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
35
Industry P/E
31
Price to Book Value
1.15
EV to EBIT
25.81
EV to EBITDA
15.87
EV to Capital Employed
1.12
EV to Sales
1.12
PEG Ratio
NA
Dividend Yield
2.52%
ROCE (Latest)
4.73%
ROE (Latest)
3.51%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company
CASH AND CASH EQUIVALENTS(HY)

Highest at Rs 37.14 cr

DEBTORS TURNOVER RATIO(HY)

Highest at 3.66 times

NET SALES(Q)

Highest at Rs 194.28 cr

-17What is not working for the Company
PBT LESS OI(Q)

At Rs 10.67 cr has Fallen at -22.06%

ROCE(HY)

Lowest at 5.38%

INTEREST(Q)

At Rs 2.67 cr has Grown at 27.75%

PAT(Q)

At Rs 9.34 cr has Fallen at -10.2%

DEBT-EQUITY RATIO(HY)

Highest at 0.31 times

Loading Valuation Snapshot...

Here's what is working for Kopran

Net Sales - Quarterly
Highest at Rs 194.28 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Cash and Cash Equivalents - Half Yearly
Highest at Rs 37.14 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Debtors Turnover Ratio- Half Yearly
Highest at 3.66 times
in the last five half yearly periods
MOJO Watch
Company has been able to settle its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Kopran

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 10.67 cr has Fallen at -22.06%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Interest - Quarterly
At Rs 2.67 cr has Grown at 27.75%
Quarter on Quarter (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Profit After Tax (PAT) - Quarterly
At Rs 9.34 cr has Fallen at -10.2%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Debt-Equity Ratio - Half Yearly
Highest at 0.31 times
in the last five half yearly periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio